202 related articles for article (PubMed ID: 8555638)
1. Erythropoietin response to blood loss in hemodialysis patients in blunted but preserved.
Ross RP; McCrea JB; Besarab A
ASAIO J; 1994; 40(3):M880-5. PubMed ID: 8555638
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
[TBL] [Abstract][Full Text] [Related]
4. Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients.
Majdan M; Ksiazek A; Bednarek-Skublewska A; Spasiewicz D
Int Urol Nephrol; 2001; 33(3):541-6. PubMed ID: 12230292
[TBL] [Abstract][Full Text] [Related]
5. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.
Gunnell J; Yeun JY; Depner TA; Kaysen GA
Am J Kidney Dis; 1999 Jan; 33(1):63-72. PubMed ID: 9915269
[TBL] [Abstract][Full Text] [Related]
6. Serum-soluble Fas and serum levels of erythropoietin in chronic kidney disease.
Góes MA; Dalboni MA; Manfredi SR; Cendoroglo MS; Batista MC; Canziani ME; Balakrishnan VS; Pereira BJ; Draibe SA; Cendoroglo M
Clin Nephrol; 2010 Jan; 73(1):7-13. PubMed ID: 20040346
[TBL] [Abstract][Full Text] [Related]
7. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
[TBL] [Abstract][Full Text] [Related]
8. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
[TBL] [Abstract][Full Text] [Related]
9. Effect of periodic transfusion on erythropoietin concentration in end stage renal disease.
Hong SY; Yang DH
Korean J Intern Med; 1992 Jul; 7(2):122-9. PubMed ID: 1306073
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
[TBL] [Abstract][Full Text] [Related]
11. Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin.
González-Ortiz A; Correa-Rotter R; Vázquez-Rangel A; Vega-Vega O; Espinosa-Cuevas Á
BMC Nephrol; 2019 Aug; 20(1):316. PubMed ID: 31412807
[TBL] [Abstract][Full Text] [Related]
12. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
[TBL] [Abstract][Full Text] [Related]
13. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin.
Moreno F; Aracil FJ; Pérez R; Valderrábano F
Am J Kidney Dis; 1996 Apr; 27(4):548-56. PubMed ID: 8678066
[TBL] [Abstract][Full Text] [Related]
14. Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin.
Matsumoto Y; Amano I; Hirose S; Tsuruta Y; Hara S; Murata M; Imai T
Blood Purif; 2001; 19(1):24-32. PubMed ID: 11114574
[TBL] [Abstract][Full Text] [Related]
15. Production of interleukin-10 in serum and erythropoietin sensitivity in ESRD patients on hemodialysis.
Attia FM; Tawfik GA; Kalil KA; Mossalam MF
Int J Lab Hematol; 2010 Oct; 32(5):524-9. PubMed ID: 20148986
[TBL] [Abstract][Full Text] [Related]
16. Influence of acetate and bicarbonate hemodialysis on the plasma erythropoietin concentration in patients with chronic renal failure.
Wiecek A; Franek E; Kokot F; Rudka R
Int J Artif Organs; 1997 Feb; 20(2):108-11. PubMed ID: 9093890
[TBL] [Abstract][Full Text] [Related]
17. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
18. Management of anemia with quotidian hemodialysis.
Rao M; Muirhead N; Klarenbach S; Moist L; Lindsay RM
Am J Kidney Dis; 2003 Jul; 42(1 Suppl):18-23. PubMed ID: 12830439
[TBL] [Abstract][Full Text] [Related]
19. [The effects of ACE inhibitor treatment and ACE gene polymorphism on erythropoiesis in chronic hemodialysis patients].
Hatano M; Yoshida T; Mimuro T; Kimata N; Tsuchiya K; Sanaka T; Nihei H
Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):632-9. PubMed ID: 11195399
[TBL] [Abstract][Full Text] [Related]
20. Effects of changes in adult erythropoietin dosing guidelines on erythropoietin dosing practices, anemia, and blood transfusion in children on hemodialysis: findings from North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS).
Twichell SA; Hunt EAK; Martz K; Somers MJG;
Pediatr Nephrol; 2020 Feb; 35(2):297-303. PubMed ID: 31709464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]